LivaNova Concludes Enrollment in OSA Neurostimulator Trial

The trial will evaluate the aura6000 System for the reduction of AHI in adults with sleep apnea who have failed or are unwilling to use CPAP.

Related Keywords

United States ,Vladimir Makatsaria ,